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Environment–environment, gene–environ-
ment, and gene–gene interactions play impor-
tant roles in determining the relationship
between exposure to environmental chemicals
and risk to human health. Traditionally,
human studies have focused on health effects
associated with exposure to a single environ-
mental chemical. These studies have been
useful for identifying human health risks
from exposure to environmental chemicals.
However, exploration of interactions among
environmental chemicals is an important area
of inquiry because it is well appreciated that
humans are exposed to a large number of
chemicals both concurrently and sequentially,
from multiple sources and through various
routes of exposure (Suk et al. 2002).
Currently, there is scientific and public
concern about potential human health risks
from exposure to phthalates, diesters of
phthalic acid. These concerns stem from stud-
ies showing that most of the U.S. general pop-
ulation is exposed to phthalates (Silva et al.
2004), as well as from animal studies suggest-
ing that some phthalates are developmental
and reproductive toxicants (Agarwal et al.
1985; Cater et al. 1977; Foster et al. 1980;
Mylchreest et al. 2000; Park et al. 2002). A
recent report on levels of phthalate monoester
metabolites in urine samples collected for the
National Health and Nutrition Examination
Survey (NHANES) 1999–2000 (Silva et al.
2004) showed that four phthalate metabolites,
namely, monoethyl phthalate (MEP), mono-
2-ethylhexyl phthalate (MEHP), monobutyl
phthalate (MBP), and monobenzyl phthalate
(MBzP), were present in more than 75%
of subjects sampled. Monoester phthalate
metabolites were measured because of poten-
tial sample contamination from the precursor
diesters and because the metabolites are con-
sidered the biologically active toxicant (Li
et al. 1998; Peck and Albro 1982).
Polychlorinated biphenyls (PCBs) are a
family of synthetic, persistent, lipophilic, poly-
aromatic chemicals found in the general U.S.
population [Centers for Disease Control and
Prevention (CDC) 2003]. Laboratory animal
and limited human studies suggest possible
associations between PCBs and semen abnor-
malities (Bush et al. 1986; Dallinga et al.
2002; Hauser et al. 2003; Richthoff et al.
2003). The half-life of PCBs in blood ranges
from 1 to ≥ 10 years (Phillips et al. 1989),
depending on congener type. Therefore,
serum levels of PCBs, which are an integrated
measure of internal dose, reflect exposure
from all sources over the previous years.
Although the use and manufacture of PCBs in
the United States were banned nearly 30 years
ago, PCBs are ubiquitous and persist in the
environment. The general population contin-
ues to be exposed to PCBs primarily through
ingestion of contaminated foods (fish, meat,
and dairy products).
In previous publications, we reported sug-
gestive evidence of inverse associations
between exposure to select PCB congeners
[i.e., PCB-138, sum of PCBs (ΣPCBs), and
PCBs classified as enzyme inducers] and
semen parameters (i.e., sperm motility and
morphology) (Hauser et al. 2003), as well as
inverse associations between exposure to
select phthalate metabolites (i.e., MBP and
MBzP) and sperm concentration and motility
(Duty et al. 2003).
Silva et al. (2003a) recently found inter-
individual differences in the percentage of
free phthalate monoesters in urine, a likely
reflection of interindividual differences in
phthalate glucuronidation. These authors
hypothesized that individual differences in
glucuronidative capacity, as measured by the
urinary levels of free phthalate monoesters,
may determine a person’s susceptibility to
phthalate toxicity. Differences in glucu-
ronidative capacity may be a result of genetic
polymorphisms in uridine 5´-diphosphate
glucuronosyltransferase (UDP-GT) or poten-
tial inhibition of UDP-GT, the enzyme
responsible for glucuronidation of phthalate
monoesters. A recently published study
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Previously, we reported evidence of inverse associations between exposure to some polychlorinated
biphenyls (PCBs) and some phthalate monoesters in relation to semen parameters, specifically
sperm motility. Because humans are exposed to both phthalates and PCBs and because experi-
mental studies suggest that PCBs may interact with glucuronidative enzymes that are responsible
for phthalate metabolism, we explored the potential interaction between phthalates and PCBs in
relation to human semen quality. We studied 303 men who were partners in subfertile couples
seeking infertility diagnosis from the andrology laboratory at Massachusetts General Hospital.
Semen parameters were dichotomized based on World Health Organization reference values, and
phthalate and PCB levels were dichotomized at their respective medians. After adjusting for age
and abstinence time, for below reference sperm motility there was a greater than additive inter-
action between monobenzyl phthalate and PCB-153 [relative excess risk due to interaction (RERI)
= 1.40; 95% confidence interval (CI), 0.41–3.22], sum of PCBs (RERI = 1.24; 95% CI,
0.15–2.94), and cytochrome P450 (CYP450)-inducing PCBs (RERI = 1.30; 95% CI, 0.21–3.06).
For below-reference sperm motility, there was also a greater than additive interaction between
monobutyl phthalate (MBP) and PCB-153 (RERI = 1.42; 95% CI, 0.09–3.76) and CYP450-
inducing PCBs (RERI = 1.87; 95% CI, 0.56–4.52) and a suggestive interaction between MBP
and sum of PCBs (RERI = 1.35; 95% CI, –0.11 to 3.48). In conclusion, because there are impor-
tant risk assessment and public health implications of interactions between these two ubiquitous
classes of compounds, further studies need to be conducted to conﬁrm these results and identify
potential mechanisms of interactions. Key words: environmental, epidemiology, human, sperm,
synergy. Environ Health Perspect 113:425–430 (2005). doi:10.1289/ehp.7305 available via
http://dx.doi.org/ [Online 10 January 2005]showed that hydroxylated PCBs (OH-PCBs)
inhibited the glucuronidation of 3-hydroxy
benzo[a]pyrene by inhibiting UDP-GT
(van den Hurk et al. 2002). On the basis of
the results of Silva et al. (2003a, 2004) and
van den Hurk et al. (2002), we conducted an
exploratory analysis of the potential statistical
interaction between serum and urinary levels
of PCBs and phthalates, respectively, in an
ongoing study on human semen quality.
Materials and Methods
This study was approved by the Harvard
School of Public Health and Massachusetts
General Hospital human subjects committees.
All subjects signed an informed consent after
receiving an explanation about the study pro-
cedures and their possible consequences. Study
subjects were men who were partners in subfer-
tile couples seeking infertility diagnosis from
the Vincent Burnham Andrology Laboratory
at Massachusetts General Hospital between
January 2000 and April 2003. One spot urine
sample and one blood sample were collected
from each subject on the same day as the
semen sample.
Additional details of subject recruitment
and the semen analysis methodologies have
been described previously (Hauser et al. 2003).
Brieﬂy, recruitment of eligible participants in
the present study has been ongoing since
January 2000. As in our earlier studies (Duty
et al. 2003; Hauser et al. 2003), sperm counts
and motility were measured by computer-
aided semen analysis using the Hamilton
Thorne IVOS 10 Analyzer (Hamilton-Thorne
Research, Beverly, MA). Sperm morphology
was scored using the strict criteria (Kruger
et al. 1988).
The analytical approach for the analysis
of urine for levels of phthalate metabolites
has been described in detail elsewhere (Silva
et al. 2003b). Briefly, phthalate metabolite
determination in urine involved enzymatic
deconjugation of the metabolites from the
glucuronidated form and then solid-phase
extraction followed by detection using
reversed-phase high-performance liquid
chromatography–isotope dilution tandem
mass spectrometry. Detection limits were in
the low nanogram per milliliter range. One
method blank, two quality control samples
(human urine spiked with phthalates), and
two sets of standards were analyzed along
with every 21 unknown urine samples.
Analysts at the CDC were blind to all infor-
mation concerning subjects. Urinary phtha-
late levels (in nanograms per milliliter) were
normalized for dilution by specific gravity
adjustment. Specific gravity was measured
using a handheld refractometer (National
Instrument Company, Inc., Baltimore, MD),
which was calibrated with deionized water
before each measurement.
Blood samples were analyzed for PCBs by
the Organic Chemistry Analytical Laboratory
at the Harvard School of Public Health. The
analytical approach has been described in
detail elsewhere (Korrick et al. 2000). Brieﬂy,
the serum extracts were analyzed by gas chro-
matography (GC) with electron capture detec-
tion (ECD) using a Hewlett-Packard 5890
Series II GC with a fused silica capillary col-
umn (DB5, 30 m × 0.25 mm, 0.25 µm; J&W
Scientiﬁc, Folsom, CA). Conﬁrmatory analysis
was performed using a Hewlett-Packard 6980
GC with a micro-ECD and capillary column
of different polarity. Quantitation was based
on the response factors of individual PCB
congeners relative to the internal standard
(PCB-166 by International Union of Pure
and Applied Chemistry nomenclature). PCB
concentrations (in nanograms per gram lipid)
were reported as individual congeners and as
the sum of all congeners measured (ΣPCBs).
The amount of each PCB congener in sam-
ples was corrected by the amount of that ana-
lyte in the procedural blank associated with
the analytical batch. Results were not adjusted
for surrogate recoveries. The percent lipid for
each serum sample was measured gravimetri-
cally, by weighing an aliquot of sample extract
evaporated to dryness.
Statistical analysis. In our previous studies
(Duty et al. 2003; Hauser et al. 2003), the
strongest relationships were found between
sperm motility and MBP, MBzP, ΣPCBs,
and PCBs classified as cytochrome P450
(CYP450) enzyme inducers (Wolff et al.
1997). Therefore, we hypothesized that inter-
actions may exist for these specific phthalate
metabolites and PCB measures and their
relationships with sperm motility. However,
to fully explore the available data, we calcu-
lated the relative excess risk due to inter-
action (RERI) between all five phthalate
monoesters [monomethyl phthalate (MMP),
MEP, MEHP, MBP, and MBzP] and the six
PCB measures [ΣPCBs, PCB-138, PCB-153,
and the three structure–activity groups of
PCBs (Wolff et al. 1997)] in relation to all
three semen parameters (i.e., sperm concen-
tration, motility, and morphology). The three
structure–activity groups of PCBs were, for
group 1, potentially estrogenic and weak
phenobarbital inducers (PCB congeners 44,
49, 52, 101, 187, 174, 177, and 157/201);
group 2, potentially antiestrogenic and
dioxin-like PCBs (PCB congeners 95/66, 74,
77/110, 105/141, 118, 156, 167, 128, 138,
and 170); and group 3, phenobarbital and
CYP1A and CYP2B inducers (PCB congeners
99, 153, 180, 196/203, and 183).
We performed multivariate logistic regres-
sion analyses to explore statistical interactions,
in terms of both departures from additivity of
relative risks (RRs) and signiﬁcance of multi-
plicative interactions. Semen parameters were
dichotomized based on the World Health
Organization (WHO) reference values
(WHO 1999) for sperm concentration
(< 20 million/mL) and motility (< 50%
motile sperm) and the strict criteria for mor-
phology (< 4% normal sperm) (Kruger et al.
1988). Because our primary objective was to
explore RR interactions, we dichotomized
PCBs and phthalates at their median levels.
We used an approach described by
Rothman (1986) to explore departure from
RR additivity, as follows: Let A and A´ denote
values above and below the median, respec-
tively, for PCBs, and let B and B´ denote val-
ues above and below the median, respectively,
for phthalates. Let RR(AB´), RR(A´B), and
RR(AB) denote the RR of having semen para-
meters below reference value for the groups of
subjects with high PCBs/low phthalates, low
PCBs/high phthalates, and high PCBs/high
phthalates, respectively, compared with the
group of subjects with low PCBs/low phtha-
lates (A´B´). RERI can be calculated as a
measure of departure from additivity using
the following equation (Rothman 1986):
RERI = RR(AB) – RR(AB´) – RR(A´B) + 1.
If there is no superadditive interaction
(null hypothesis), RERI equals 0. If there is
superadditivity, RERI is > 0, and subadditivity
will yield an RERI < 0. Indicator variables for
the exposure categories AB, A´B, and AB were
created using the category A´B´ as the refer-
ence category. Odds ratios (ORs) were esti-
mated by exponentiating the corresponding
coefﬁcients from the multiple logistic regres-
sion model. The ORs were substituted for the
RRs in the RERI equation. Conﬁdence inter-
vals (CIs) for the RERI were calculated using
bootstrap percentile 1 methodology recom-
mended by Assmann et al. (1996). For exam-
ple, for a 95% CI these are essentially the
lower 2.5th and upper 2.5th percentiles of the
empirical distribution of RERIs calculated
from 500 data sets resampled with replace-
ment from the original data.
To explore the signiﬁcance of a multiplica-
tive interaction between the dichotomized
phthalate and PCB levels, a standard inter-
action term was included in the logistic
regression models. Statistical significance of
the interaction term was determined by calcu-
lating p-values based on Wald tests for the
multiplicative interaction term (Hosmer and
Lemeshow 1989). In addition, the predicted
probabilities of below reference semen para-
meters were calculated from the logistic
regression models that included both main
effects of the phthalates and PCBs and their
multiplicative interaction.
Covariates considered for inclusion in the
multivariate logistic models included smoking
status, age, and abstinence time (Blackwell and
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1994). Their ﬁnal inclusion in the multivariate
models was based on statistical and biologic
considerations (Hosmer and Lemeshow 1989).
Age was modeled as a continuous independent
variable. Abstinence time was modeled as an
ordinal ﬁve-category variable (i.e., < 2, 3, 4, 5,
and ≥ 6 days). Smoking status was included as
a dummy variable (current and former vs.
never). All statistical analyses were conducted
using SAS software, version 8.2 (SAS Institute
Inc., Cary, NC).
Results
Participants and semen parameters.
Demographic characteristics by sperm motil-
ity are described in Table 1 for the 303 study
subjects. An additional 25 subjects with
semen and PCB measures were excluded
from the statistical analysis because they
lacked phthalate measurements. Subjects
were primarily white (82%) and had a mean
(± SD) age of 36.0 ± 5.4 years, and 72% had
never smoked. Using the WHO reference
values (WHO 1999), 53 men (17%) had low
sperm concentrations, 145 men (48%) had
low percentages of motile sperm, and 78 men
(26%) had abnormal sperm morphology.
The semen parameter categories were not
mutually exclusive (i.e., a man could be clas-
sified as having below reference values for
more than one of the sperm parameters).
Subjects having below reference sperm motil-
ity tended to be older than those having
above reference sperm motility (Wilcoxon
rank sum test, p = 0.02). There was no clear
association of sperm concentration, motility,
or morphology with either abstinence time or
smoking status.
Phthalate monoesters and PCBs. There
was a wide distribution of both PCBs and
phthalate monoester levels (Tables 2 and 3,
respectively). The rank order of the phthalate
distribution was similar to the distribution
found in NHANES 1999–2000 (Silva et al.
2004), with the highest median levels found
for MEP (148 ng/mL), followed by MBP
(15.1 ng/mL), MBzP (7.0 ng/mL), MEHP
(5.4 ng/mL), and MMP (4.5 ng/mL). MMP
was not measured in the NHANES
1999–2000 population. The median concen-
tration of the ΣPCBs was 212 ng/g lipid.
Interaction analyses. To explore the main
effects of the phthalate monoesters and the
PCBs with semen parameters, separate logistic
regression models were fitted in which each
semen parameter was regressed on pairs of
one phthalate and one PCB in each model.
Although models were run for each semen
parameter, only models for sperm motility are
presented because they had the strongest asso-
ciations with phthalate monoesters and PCBs.
There was an association between below refer-
ence value sperm motility and MBP above the
median (OR = 1.65; 95% CI, 1.04–2.62) and
a suggestive association between sperm motil-
ity and PCBs classified as CYP450 enzyme
inducers (OR = 1.38; 95% CI, 0.84–2.27).
These ORs represent the ORs for MBP (or
enzyme-inducing PCBs) pooled over both
high and low levels of the other analyte. There
were suggestive relationships between sperm
motility and the ΣPCBs (OR = 1.48; 95% CI,
0.90–2.43) and PCB-153 (OR = 1.41; 95%
CI, 0.86–2.29). In models with MBzP and
PCBs, there was no association of sperm
motility with MBzP (OR = 1.07; 95% CI,
0.67–1.69) but suggestive associations with
the ΣPCBs (OR = 1.51; 95% CI, 0.92–2.46),
PCB-153 (OR = 1.44; 95% CI, 0.89–2.34),
and PCBs classified as CYP450 enzyme
inducers (OR = 1.41; 95% CI, 0.86–2.32).
Although these pooled ORs may be non-
signiﬁcant in the main effect models, it should
be noted that such estimates may not be
appropriate summary measures of effects in
the presence of interactions.
In the models exploring the additive inter-
actions between dichotomized phthalates and
PCBs, both crude and adjusted ORs for low
sperm motility were calculated (Table 4). The
crude ORs were nearly identical to the
adjusted ORs (coefficients were within 5%)
and therefore are not presented. After adjust-
ment for age and abstinence time, men with
MBP levels above the median and the sum of
enzyme-inducing PCB levels below the median
(high MBP/low PCB) and men with MBP lev-
els below the median and the sum of enzyme-
inducing PCB levels above the median (low
MBP/high PCB) were not more likely to have
sperm motility values below the WHO refer-
ence value (low MBP/low PCB) (OR = 1.0;
95% CI, 0.55–1.86 and OR = 0.89; 95% CI,
0.47–1.67, respectively) than men with both
MBP and the sum of enzyme-inducing PCB
levels below the median. In contrast, men with
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Table 1. Demographic characteristics by sperm
motility (n = 303).
Sperm motility
Total ≥ 50% < 50%
subjects motile motile
(n = 303) (n = 158) (n = 145)
Age
Median (years) 35.0 35.0 36.0
Categories [n (%)]
≤ 30 years 39 (13) 25 (16) 14 (10)
31–35 years 114 (38) 70 (44) 44 (30)
36–40 years 96 (32) 38 (24) 58 (40)
> 41 years 54 (18) 25 (16) 29 (20)
Abstinence time [n (%)]
≤ 2 days 73 (24) 39 (25) 34 (23)
3 days 96 (32) 49 (31) 47 (32)
4 days 51 (17) 25 (16) 26 (18)
5 days 27 (9) 16 (10) 11 (8)
≥ 6 days 54 (18) 28 (18) 26 (18)
Unknown 2 (1) 1 (1) 1 (1)
Smoking status [n (%)]
Never smoker 217 (72) 115 (73) 102 (70)
Ever smoker 83 (27) 42 (27) 41 (28)
Unknown 3 (1) 1 (1) 2 (1)
Pearson’s chi-square test for smoking status, p-value = 0.71;
Mantel-Haenszel chi-square test for trend for abstinence
time, p-value = 0.95 (subjects with unknown smoking status
or abstinence time were excluded from the chi-square
tests); Wilcoxon rank sum test for age, p-value = 0.02.
Table 2. Distribution of serum levels (in ng/g lipid) of PCB-118, PCB-138, PCB-153, and ΣPCBs, and
structure–activity groupings of PCBs (n = 303).
Percentile Geometric
5th 25th 50th 75th 95th mean
PCB-118 4.4 7.6 11.9 18.5 35.2 12.1
PCB-138 14.0 22.2 31.2 47.8 102 33.4
PCB-153 17.5 27.7 40.9 60.4 125 43.0
ΣPCB congeners 92.3 152 212 312 592 223
ΣEstrogenic PCBs (group 1) 6.8 10.6 15.5 22.1 47.8 16.1
ΣDioxin-like PCBs (group 2) 36.9 54.8 74.3 117 227 80.6
ΣEnzyme-inducing PCBs (group 3) 36.3 59.9 87.8 133 263 91.8
Table 3. Distribution of urinary phthalate monoester concentrations (in ng monoester/mL urine) unadjusted
and adjusted for speciﬁc gravity (n = 303).
Percentile Geometric
5th 25th 50th 75th 95th mean
Unadjusted
MEP 16.9 48.7 148 514 1,937 160
MBP 2.3 7.8 15.1 31.8 75.1 14.7
MBzP < LOD 2.9 7.0 14.4 35.0 6.3
MEHP < LOD 2.0 5.4 20.6 131 5.9
MMP < LOD 1.7 4.5 10.9 32.1 3.9
Speciﬁc gravity adjusted
MEP 25.0 60.0 165 528 1,974 185
MBP 3.6 10.3 16.3 31.0 68.2 17.0
MBzP < LOD 4.1 8.0 14.3 37.6 7.3
MEHP < LOD 2.4 6.6 20.4 112 6.9
MMP < LOD 2.2 5.0 11.8 32.5 4.5
LOD, limit of detection (MBzP = 0.5 ng/mL; MEHP = 0.9 ng/mL; MMP = 0.7 ng/mL).both MBP and the sum of enzyme-inducing
PCB levels above the median (high MBP/high
PCB) were 2.77 times (95% CI, 1.47–5.19)
more likely to have sperm motility values
below the reference value than men with low
MBP/low PCBs.
After adjustment for age and abstinence
time, there was a greater than additive inter-
action between MBP and sum of enzyme-
inducing PCBs (RERI = 1.87; 95% CI,
0.56–4.52) for the risk of below reference
sperm motility. There was also an interaction
between MBP and PCB-153 (RERI = 1.42;
95% CI, 0.09–3.76) and a suggestive inter-
action between MBP and ΣPCBs (RERI =
1.35; 95% CI, –0.11 to 3.48). Similarly, for
MBzP, there were interactions with sum of
CYP450 enzyme-inducing PCBs (RERI =
1.30; 95% CI, 0.21–3.06), PCB-153 (RERI
= 1.40; 95% CI, 0.41–3.22), and the ΣPCBs
(RERI = 1.24; 95% CI, 0.15–2.94) (Table 4).
There were no significant interactions
between the other phthalates (MEP, MMP,
and MEHP) and PCBs (PCB-118, PCB-138,
PCB-153, and the three groupings of PCBs)
with sperm motility. Similarly, there were no
significant interactions between any phtha-
lates and PCBs with sperm concentration or
morphology.
Typically, the magnitudes of interactions
that are detected as consistent with a multi-
plicative interaction term are much larger than
those that might be statistically detected as
greater than additive. However, in our analysis
we found that evaluation of interaction on the
multiplicative scale yielded results very similar
to those of the RERI measures and their sig-
nificance. After adjusting for age and absti-
nence time, for below reference sperm motility
values, there were multiplicative interactions
between MBP and PCB-153 (p-value = 0.07)
and group 3 PCBs (p-value = 0.008), as well as
interactions between MBzP and the ΣPCBs
(p-value = 0.02), PCB-153 (p-value = 0.004),
and group 3 PCBs (p-value = 0.01). There was
a suggestive multiplicative interaction between
MBP and ΣPCBs (p-value = 0.12).
The predicted percentages of men with
below reference sperm motility based on the
interactions between levels of MBP and MBzP
with PCBs are presented in Table 5. The table
shows the percentage of subjects with below
reference sperm motility; it does not show the
percentage of motile sperm. For instance, the
predicted percentages of men with below ref-
erence sperm motility values by MBP and
group 3 PCBs were 45% for subjects with low
MBP/low group 3 PCBs, 37% for subjects
with low MBP/high group 3 PCBs, 42% for
subjects with high MBP/low group 3 PCBs,
and 65% for subjects with high MBP/high
group 3 PCBs.
Discussion
In the present study, we found evidence of
interactions between some PCBs and phtha-
lates in relation to alterations in human sperm
motility. Specifically, we found interactions
between MBP and MBzP with enzyme-
inducing PCBs, ΣPCBs, and PCB-153 in
relation to sperm motility. We recognize that
this was an exploratory analysis that involved
multiple comparisons. However, because this
was one of the first studies to explore inter-
actions among these families of chemicals, we
felt it was important to examine all potential
phthalate monoesters and PCB category com-
binations even though our a priori hypothesis
for interactions included only MBP, MBzP,
ΣPCBs, and PCBs classified as CYP450
enzyme inducers.
One potential limitation of our analysis
method is that we grouped the levels of both
phthalates and PCBs into “low” and “high”
levels based on their medians in order to take
advantage of the RERI approach for evaluat-
ing greater than additive interaction. As a
result, it is hypothetically possible that the
interactions observed could be an artifact of
higher underlying levels of one compound at
the “high” level of the other compound com-
pared with the “low” level of the other com-
pound. However, for our study we found that
this was not the case; the mean underlying lev-
els of MBP and MBzP were essentially equiva-
lent between low and high levels of each of the
three PCB groups, and the mean underlying
levels of the groups of PCBs, although slightly
higher for “high” MBP (or MBzP) than for
“low” MBP (or MBzP) within the “high”
PCB groups, were never signiﬁcantly higher.
In addition, the interaction between MBzP
and each of the PCB measures (ΣPCBs,
PCB-153, and enzyme-related PCBs) was sta-
tistically signiﬁcant even when the underlying
continuous measures were used as main effects
and multiplicative interactions, supporting the
validity of our analysis.
Although we are not aware of animal or
human data on the interaction of phthalates
and PCBs in relation to sperm motility, there
are data on their independent relationships
with sperm motility. Bush et al. (1986) found
signiﬁcant inverse relationships between sperm
motility and seminal plasma concentrations of
PCB congeners 153, 138, and 118. Dallinga
et al. (2002) analyzed serum for PCB con-
geners 118, 138, 153, and 180 and their
metabolites and found an inverse relationship
between the sum of PCB metabolites and
sperm progressive motility and concentration.
In another recently published study, Richthoff
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Table 4. Adjusteda ORs (95% CIs) for low sperm motility, and RERI for the additive interactions between
two phthalates (MBP and MBzP) and three categories of PCBs (enzyme-inducing PCBs, ΣPCBs, and PCB-
153).
Phthalate Exposure level OR by PCB category
monoester Phthalateb PCBb Nos.c Enzyme-inducing PCBs ΣPCBs PCB-153
MBP Low Low 80, 80, 80 1.0 1.0 1.0
High Low 71, 71, 71 1.00 (0.55–1.86) 1.26 (0.68–2.34) 1.21 (0.66–2.23)
Low High 72, 72, 72 0.89 (0.47–1.67) 1.19 (0.63–2.24) 1.07 (0.57–2.01)
High High 80, 80, 80 2.77 (1.47–5.19) 2.80 (1.50–5.23) 2.68 (1.44–4.99)
RERI 1.87* (0.56–4.52) 1.35 (–0.11–3.48) 1.42* (0.09–3.76)
MBzP Low Low 69, 73, 70 1.0 1.0 1.0
High Low 82, 78, 81 0.73 (0.40–1.34) 0.73 (0.39–1.34) 0.68 (0.37–1.26)
Low High 83, 79, 82 1.00 (0.54–1.85) 1.07 (0.57–2.00) 0.94 (0.51–1.75)
High High 69, 73, 70 2.03 (1.05–3.92) 2.03 (1.08–3.85) 2.03 (1.06–3.89)
RERI 1.30* (0.21–3.06) 1.24* (0.15–2.94) 1.40* (0.41–3.22)
aAdjusted for age and abstinence time. bMBP, MBzP, and PCBs were dichotomized at their median: “low” indicates expo-
sure below the group median, and “high” indicates exposure above the group median. cNumbers of subjects in each of
the paired phthalate and PCB categories, respectively. *p < 0.05.
Table 5. Adjusteda predicted percentages of men with below-reference sperm motility by high or low lev-
els of two phthalates (MBP and MBzP) and three categories of PCBs (enzyme-inducing PCBs, ΣPCBs, and
PCB-153).
Predicted percentages by PCB category
Phthalate Exposure level Enzyme-inducing
monoester Phthalateb PCBb Nos.c PCBs ΣPCBs PCB-153
MBP Low Low 80, 80, 80 45 41 42
High Low 71, 71, 71 37 42 40
Low High 72, 72, 72 42 44 44
High High 80, 80, 80 65 63 63
MBzP Low Low 69, 73, 70 50 49 50
High Low 82, 78, 81 43 44 42
Low High 83, 79, 82 37 36 36
High High 69, 73, 70 60 60 61
aAdjusted for age and abstinence time. bMBP, MBzP, and PCBs were dichotomized at their median: “low” indicates expo-
sure below the group median, and “high” indicates exposure above the group median. cNumbers of subjects in each of
the paired phthalate and PCB categories, respectively.et al. (2003) found weak but statistically signif-
icant negative associations between PCB-153
and sperm motility. In our previous publica-
tion (Hauser et al. 2003), we found evidence of
inverse associations between PCB-138,
ΣPCBs, and PCBs classiﬁed as enzyme induc-
ers, and sperm motility and morphology.
OH-PCBs, formed by CYP1A and
CYP2B during the phase I metabolism of
PCBs, have been found in human blood at
levels comparable with the parent PCBs
(Bergman et al. 1994; Fangstrom et al. 2002;
Hovander et al. 2002; Letcher et al. 2000).
Although we did not measure OH-PCBs in
the present study, future plans include meas-
uring OH-PCBs, potentially strengthening
the relationships previously found between
some groups of PCBs and semen parameters
(Hauser et al. 2003), as well as potentially
strengthening the interactions found between
some groups of PCBs and phthalates in the
present study.
Toxicologic studies, primarily in rats, con-
sistently show that select phthalate monoesters,
including MEHP, MBzP, and MBP, are male
reproductive toxicants (Cater et al. 1977;
Foster et al. 1981; Oishi 1986; Park et al.
2002). Testicular toxicity, manifesting as
testicular atrophy and spermatogenic cell loss,
was found after phthalate exposure. The Sertoli
cell is considered the primary target of phtha-
late monoester toxicity. Phthalate monoesters
affect the normal nurse function of the Sertoli
cell and its ability to produce lactate and pyru-
vate from glucose, an essential function of the
Sertoli cell in the sustenance of germ cells,
which cannot use glucose as an energy sub-
strate (Williams and Foster 1988). Studies have
also shown that select phthalate monoesters
may interfere with the ability of Sertoli cells to
respond to their normal endogenous ligand,
follicle-stimulating hormone (FSH). MBP and
MEHP inhibit the ability of the FSH to stimu-
late its normal cellular second messenger,
cAMP (Heindel and Chapin 1989; Heindel
and Powell 1992; Lloyd and Foster 1988).
These studies showed that the site of action of
the phthalate monoester was at the coupling of
the FSH receptor–ligand complex to the trans-
ducing G-protein within the Sertoli cell mem-
brane. Dimethyl and diethyl phthalate were
without Sertoli cell effects even at high dose
levels (Heindel and Powell 1992). Phthalate
monoester toxicity has also been found to be
associated with an increased rate of apoptosis
of germ cells (Richburg and Boekelheide
1996), which may be partially responsible for
the loss of spermatogenic cells in the testis.
Because of the ongoing recruitment of par-
ticipants for our research, the subjects in the
present study overlap with the subjects in our
previous studies on the independent associa-
tions between exposure to PCBs (Hauser et al.
2003) and phthalates (Duty et al. 2003) with
human semen parameters. Because all subjects
in our studies were partners of an infertile cou-
ple, the generalizability of our results to men in
the general population remains unclear because
men visiting an infertility clinic may be more
susceptible to environmental chemicals than
men from the general population. However,
there is currently no evidence to support or
refute the hypothesis that men attending an
infertility clinic are more susceptible to PCBs
or phthalates than any other group of men.
Conclusion
An understanding of how chemical classes
interact is essential to determining risk because
humans are concurrently exposed to numerous
classes of chemicals, including phthalates and
PCBs (CDC 2003). In the present study, we
found statistical interactions between some
PCBs and phthalates in relation to low sperm
motility. Although our study was not designed
to determine the biologic mechanism(s) under-
lying statistical interactions, we hypothesize
that the mechanism is through interactions
between PCB metabolites and enzymes
responsible for phthalate metabolism, speciﬁ-
cally UDP-GT. Our future work will include
measures of PCB metabolites, as well as levels
of free and glucuronidated phthalate mono-
esters in urine. This will allow us to directly
explore the potential inhibitory action of PCB
metabolites on the glucuronidation of phtha-
late monoesters.
If there are interactions between these two
ubiquitous classes of chemicals, risk assess-
ments for human exposure to phthalates
would need to be revised to account for a
potentially increased risk of altered semen
quality in the presence of exposure to PCBs.
The risk assessment and public health impli-
cations of an interaction between these two
ubiquitous classes of compounds make it
important to conduct further human studies
to conﬁrm these results and identify potential
mechanisms of interactions.
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